logo
Odisha reports seven new COVID-19 cases; tally rises to 30

Odisha reports seven new COVID-19 cases; tally rises to 30

Bhubaneswar, June 6 (UNI) With seven new COVID-19 positive cases detected in the past 24 hours, the COVID-19 tally in Odisha has risen to 30, official sources said here on Friday.
Odisha Public Health Director Nilakatha Mishra said that out of the 30 cases, seven patients have already recovered from the virus, leaving the state with 23 active cases.
He, however, said the situation is under control and clarified that none of the 23 active cases are serious in nature.
The state government has not yet issued any advisory or guidelines and is in touch with the Centre.
Mishra urged people not to panic, stating that so far, the COVID-19 positive cases detected in the state have been caused by mild sub-variants of Omicron.
Most of the cases, official sources said, have been detected in the twin cities of Bhubaneswar and Cuttack, as well as Khordha district.
Khordha district, with 16 COVID-19 positive cases, topped the list, followed by Cuttack, which has recorded nine active cases.
Other districts where COVID-19 positive cases have been reported include Puri, Jagatsinghpur, Keonjhar, Sundargarh, and Balasore.
UNI DP ARN

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IIT Guwahati Researchers Use Clay-Based Method To 'Sculpt' Affordable Covid Testing Process
IIT Guwahati Researchers Use Clay-Based Method To 'Sculpt' Affordable Covid Testing Process

News18

time19 minutes ago

  • News18

IIT Guwahati Researchers Use Clay-Based Method To 'Sculpt' Affordable Covid Testing Process

Last Updated: The IIT Guwahati team meticulously investigated how bentonite clay interacts specifically with SARS-CoV-2 Researchers at the Indian Institute of Technology (IIT) Guwahati have developed an innovative and cost-effective method for detecting SARS-CoV-2, the virus responsible for Covid-19. This novel technique uses a combination of bentonite clay and saltwater, offering a simpler and more affordable alternative to conventional diagnostic tools such as PCR and antigen tests. Their findings, published in the peer-reviewed journal Applied Clay Science, have the potential to revolutionise virus detection, particularly in resource-constrained settings and for future pandemic preparedness. This groundbreaking method hinges on the principle of sedimentation. Bentonite clay is renowned for its exceptional absorbent properties and its capacity to bind with various substances, including heavy metals and pollutants. Building on previous research suggesting that clay particles could interact with viruses, the IIT Guwahati team meticulously investigated how bentonite clay interacts specifically with SARS-CoV-2. Their research revealed that when the virus is present in a neutral pH saltwater solution at room temperature, it binds effectively with the clay particles. This binding accelerates sedimentation, with virus-laden clay particles settling more rapidly. By observing and measuring this accelerated sedimentation, researchers can accurately determine both the presence and concentration of the virus in a sample. The implications of this discovery are substantial, say some experts. While PCR tests are highly accurate, they are costly, require specialised equipment and trained personnel, and often depend on significant infrastructure, limiting their accessibility in remote or under-resourced areas. Antigen tests, while faster, can be less sensitive than PCR. In contrast, the IIT Guwahati method requires minimal equipment, is inherently affordable, and offers a potentially rapid diagnostic solution suitable for widespread deployment. First Published: June 07, 2025, 04:03 IST

When diseases cross borders, so must solidarity
When diseases cross borders, so must solidarity

New Indian Express

timean hour ago

  • New Indian Express

When diseases cross borders, so must solidarity

Even as the US, led by President Donald Trump, withdrew from global health engagements through a petulant exit from the World Health Organization (WHO) and the evisceration of its international aid agency, two events in Geneva on May 19 unfurled the flag of global solidarity. One, international negotiations on the Pandemic Treaty ended, with all participating WHO members agreeing on the final text. The treaty was cheered by an anxious world badly bruised by Covid's devastation and wary of more zoonotic pandemics on the horizon. It is the second-ever global health treaty to be concluded under auspices of the WHO, after the Framework Convention for Tobacco Control adopted in 2003. The second was the convening of a forum—Digital Health Without Borders—to advance digital health applications across the world with impact, efficiency and equity. The event, organised by Dr Rajendra Gupta from India, was addressed by WHO's Director General Tedros Adhanom Ghebreyesus and leading digital technology experts as well as prominent representatives from the domains of medicine, nursing and public health. They advocated universal access to impactful digital health technologies to prevent pandemics and promote primary care-led universal health coverage. These affirmations of a 'one world' approach are reassuring in a polarised political environment where the US and some other countries are retreating from adherence to principles of global solidarity. While the US and Argentina have quit the WHO, western European nations like the Netherlands and Germany have reduced their commitments to global aid. Trump and Musk have eviscerated USAID, which was a major contributor to global health programmes aimed at tackling infectious diseases like HIV-AIDS and tuberculosis, as well as maternal and child health protection. Scientific agencies like the National Institutes of Health have been disconnected from global research.

Covid Virus's Bodyguard: How Pathogen Protects Itself While Replicating
Covid Virus's Bodyguard: How Pathogen Protects Itself While Replicating

News18

time2 hours ago

  • News18

Covid Virus's Bodyguard: How Pathogen Protects Itself While Replicating

Last Updated: US study highlights that disrupting this protective shield significantly reduces the virus's ability to spread, which could be key to developing more effective antiviral treatments Scientists from the Texas Biomedical Research Institute and the University of Chicago have made a significant breakthrough in understanding SARS-CoV-2, the virus responsible for Covid-19. Their collaborative efforts have identified a crucial self-protective mechanism that the virus uses within the human body, enabling it to replicate effectively and infect more cells. The study highlights that disrupting this protective shield significantly reduces the virus's ability to spread, emphasising its critical role in viral propagation. The research reveals that SARS-CoV-2 is not just an invading pathogen but a sophisticated entity that actively protects itself during the infection process. This newly discovered mechanism allows the virus to survive and multiply within host cells, bypassing the body's natural defences. Scientists observed a direct correlation: interference with this shielding process led to a significant drop in the viral infection rate. This finding, published in the journal Nature Communications, strongly suggests that understanding and potentially targeting this protective strategy could be key to developing more effective antiviral treatments. While the initial report does not delve into the specific molecular or cellular details of how this mechanism operates, its identification marks a pivotal moment in Covid-19 research. Scientists emphasise its profound importance in deciphering the intricate ways the virus spreads at a cellular level. Unravelling this protective shield could open new avenues for therapeutic intervention, potentially leading to drugs that disarm the virus's ability to protect itself, thereby limiting its replication and spread within an infected individual. This discovery holds promise for a more targeted approach to combating Covid-19. By understanding the virus's internal defences, researchers can work towards developing antiviral therapies that specifically dismantle this protective mechanism, rather than relying solely on broad-spectrum approaches. (With agency inputs) First Published: June 06, 2025, 18:46 IST

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store